Roche Holding Ltd

Filings by Roche Holding Ltd span 6 companies, the busiest being Bioveris Corp, Entrada Therapeutics, Inc. and Pandion Therapeutics, Inc. Over a trading history stretching from 26 June 2007 to 25 January 2023, the count stands at 10 filings.

Both buying and selling appear: 4 purchases worth €2.2M, against 1 sale worth €130k. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2023 alone, the filings show no purchases and 1 sale.

In size, the median ticket on the buying side is €564k.

The record was last updated on 26 January 2023 with an open-market sale (€130k) in Jasper Therapeutics, Inc. The most recent open-market purchase was published on 23 July 2020, 2,284 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.